NASHVILLE, TN (WSMV) - A report filed by the Tennessee Bureau of Investigation is painting a clearer picture of the events that led to a patient receiving a fatal dose of the wrong drug while she was at Vanderbilt University Medical Center.

75-year-old Charlene Murphy died December 26, 2017 after receiving a fatal dose of Vecuronium Bromide, a drug that causes paralysis. Murphy was supposed to receive Versed, which treats anxiety.

Radonda Vaught is the nurse who administered the wrong drug. She is facing charges of patient abuse and reckless homicide. Vaught was let go from VUMC January 3, 2018.

The TBI's investigative report of the incident was released Wednesday. Investigators say Vaught admitted thinking, "I probably just killed a patient" after the incident, which she described as a "horrible situation." Vaught said she "f---ed up." 

Prosecutors say Vaught missed at least 10 warnings and red flags in the process of administering the deadly drug, including multiple warnings that the drugs is a "paralyzing agent."

The bottle for Vecronium Bromide is red and the cap reads "WARNING: PARALYZING AGENT." Prosecutors say she would have had to look directly at that warning while drawing the medication into the syringe.

Vaught told investigators she was distracted talking to a new employee during the incident.

Copyright 2019 WSMV (Meredith Corporation). All rights reserved.

Multimedia Producer

Kyle is a Multimedia Producer at WSMV. He is a proud graduate of Virginia Tech, where he majored in multimedia journalism with a minor in psychology. Send news tips to

Recommended for you

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.